Newsroom | 9156 results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today reported financial results for its fiscal year 2026 first quarter ended June 30, 2025, and provided a corporate update. “We had another productive quarter, advancing key programs across our pipeline,” said Shawn Singh, Presid...

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, is reaching additional global healthcare providers eager to use its PrecivityAD2™ blood test to help diagnose Alzheimer’s disease. The PrecivityAD2™ blood test allows healthcare providers to determine the presence or absence of amyloid pathology, a known hallmark of Alzheimer’s disease, for patients being evaluated for cognitive complaints through a simpl...

MCLEAN, Va.--(BUSINESS WIRE)--Leading provider of developmental therapy for autistic children and their families, Positive Development announces $51.5M in Series C funding....

WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, a leader in ambulatory cloud EHR solutions, today announced that Evolve Psychiatry is successfully utilizing Sunoh.ai, the AI-powered ambient listening solution, at its practice. This implementation has revolutionized clinical documentation by saving providers over two hours daily, enhancing accuracy, and improving workflow efficiency. “Sunoh.ai has transformed how we operate at Evolve Psychiatry,” said Dr. Priyadarshan Bajpayi, CEO at Evolv...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity 45th Annual Growth Conference, on August 12, 2025 in Boston, MA. Mr. Drysdale’s fireside cha...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13, 2025 at 2:30 p.m. Eastern Time. A live webcast of Acadia’s fireside chat will be accessible on the company’s website, Acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following the presentation. About Acadia Pharma...

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--The Best Treatment Centers, founded by Dustin Pillonato, is preparing to open a new facility in West Palm Beach, Florida. This upcoming location represents a key milestone in the organization’s mission to expand access to high-quality, compassionate care for individuals facing addiction and mental health challenges. Located in the heart of Palm Beach County, the new center will provide a full range of services, including individualized therapy, group coun...

STAMFORD, Conn.--(BUSINESS WIRE)--AI-powered solutions for data queries, solution building, talent acquisition and mental wellness won the ISG Startup Challenges at recent ISG events....

CHICAGO--(BUSINESS WIRE)--Molina Healthcare of Illinois invests $1.6 million to improve access to health care....

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Management will participate in the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA, with a company presentation scheduled at 4:00pm ET. A broadcast of Compass’s presentation will be accessible from the “Events” page of the Investors section of the Compass webs...